Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $27.55 USD
Change Today -0.07 / -0.25%
Volume 46.8K
ENTL On Other Exchanges
As of 8:10 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

entellus medical inc (ENTL) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/16/15 - $28.81
52 Week Low
01/29/15 - $19.00
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ENTELLUS MEDICAL INC (ENTL)

Related News

No related news articles were found.

entellus medical inc (ENTL) Related Businessweek News

No Related Businessweek News Found

entellus medical inc (ENTL) Details

Entellus Medical, Inc., a medical technology company, focuses on the design, development, and commercialization of products for the minimally invasive treatment of patients suffering from chronic sinusitis. The company offers XprESS Multi-Sinus Dilation family of products consisting of XprESS Pro device, XprESS LoProfile device, and XprESS Ultra device, which open an obstructed or narrowed drainage pathway of a sinus cavity by means of trans-nasal balloon sinus dilation; and FinESS sinus dilation system, a solution for treatment of the maxillary sinus drainage pathway. It also provides PathAssist tools, such as LED Light Fiber, a single-use tool that provides real-time high intensity red trans-illumination of the sinus cavity with its own battery power; Light Fiber, a single-use tool that provides real-time trans-illumination of the sinus cavity; Light Seeker, a tool with optical fibers embedded into the device to allow ear, nose, and throat (ENT) physicians to access the frontal sinus and trans-illuminate the sinus cavity, and forehead to confirm correct entry into the frontal sinus; Maxillary Seeker, a tool that allows users to find the correct angle to access the natural maxillary ostia; and Sphenoid Seeker/Freer, a two-in-one tool that enables ENT physicians to navigate access to the sphenoid ostium, and to manipulate the middle turbinate. In addition, Entellus Medical, Inc. distributes XeroGel Nasal Packing Material for use in patients undergoing nasal or sinus surgery, as well as for use as a nasal packing to treat epistaxis or nasal bleeding. The company sells its products in the United States. Entellus Medical, Inc. was founded in 2006 and is headquartered in Plymouth, Minnesota.

177 Employees
Last Reported Date: 03/19/15
Founded in 2006

entellus medical inc (ENTL) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $93.0K
Executive Chairman
Total Annual Compensation: $458.9K
Vice President of Clinical, Regulatory & Qual...
Total Annual Compensation: $240.0K
Vice President of Sales
Total Annual Compensation: $290.0K
Compensation as of Fiscal Year 2014.

entellus medical inc (ENTL) Key Developments

Entellus Medical, Inc. Announces Executive Changes

Entellus Medical, Inc. announced that Robert White, President and Chief Operating Officer of the company has been promoted to President and Chief Executive Officer and appointed to its Board of Directors. In a planned move, Brian Farley, the company's current Chairman and Chief Executive Officer, has transitioned to Executive Chairman of the Board and part-time employment with the company. Mr. White joined Entellus Medical in November 2014 as President and Chief Operating Officer and has been responsible for Sales, Marketing, International, R&D, and Manufacturing Operations. From January 2010 to March 2014, Mr. White served as President and CEO of TYRX, Inc. Prior to joining TYRX, Mr. White served as President of Medtronic Kyphon, President of Medtronic Physio Control, and in various business development positions at Medtronic Inc. and Eli Lilly and Company. Mr. White serves on the Board of Directors of publicly traded companies, Novadaq Technologies and Atricure Inc., as well as privately owned HyperBranch Medical Technology Inc.

Entellus Medical, Inc. Enters into an Amendment to Amended and Restated Loan and Security Agreement with Oxford Finance

On March 30, 2015, Entellus Medical, Inc. entered into an amendment to the company's amended and restated loan and security agreement with Oxford Finance LLC and the lenders listed therein. Among other things, the Amendment (i) changes the company's obligation to deliver consolidated financial statements to the lenders from monthly to quarterly (except for the last quarter of the company's fiscal year, so long as the Company is required to make periodic filings with the Securities and Exchange Commission), (ii) extends the timeframe in which the company must comply with such requirement from 30 days after the end of the month to 45 days after the end of the quarter, and (iii) requires that the company deliver the lenders a consolidated statement of revenue for the first two months of each fiscal quarter.

Entellus Medical, Inc.(NasdaqGM:ENTL) added to Russell 2000 Index

Entellus Medical, Inc. has been added to Russell 2000 Index.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENTL:US $27.55 USD -0.07

ENTL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Stryker Corp $92.90 USD -0.73
View Industry Companies

Industry Analysis


Industry Average

Valuation ENTL Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.9x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 8.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENTELLUS MEDICAL INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at